Top Buy
Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €62.00 | €79.55 | 28.313% |
TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.83 | €28.06 | 77.242% |
Esperion Therapeutis.Inc. | 15 | 0 | 4 | 0 | €1.97 | €8.39 | 325.372% |
Evolus Inc | 9 | 0 | 4 | 0 | €12.10 | €20.43 | 68.864% |
Geron Corp. | 12 | 0 | 4 | 0 | €3.61 | €4.63 | 28.316% |
Krystal Biotech | 17 | 0 | 4 | 0 | €145.65 | €179.60 | 23.306% |
Addus Homecare Corp. | 15 | 1 | 4 | 1 | €95.50 | €103.07 | 7.927% |
Twist Bioscience Corp | 7 | 0 | 4 | 0 | €39.54 | €41.41 | 4.727% |
Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €23.65 | €35.43 | 49.807% |
Heron Therapeutics Inc. | 10 | 1 | 4 | 0 | €2.73 | €4.58 | 67.410% |
AnaptysBio Inc | 9 | 1 | 4 | 0 | €23.80 | €46.24 | 94.286% |
G1 Therapeutics | 15 | 1 | 3 | 0 | €4.77 | €10.56 | 121.177% |
Biocryst Pharmaceuticals | 10 | 0 | 3 | 0 | €4.91 | €11.05 | 124.857% |
Galmed Pharmaceuticals Ltd. | 7 | 0 | 3 | 0 | €0.36 | €63.93 | 17560.497% |
EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 1 | €11.83 | €27.83 | 135.258% |
X4 Pharmaceuticals, Inc. | 6 | 0 | 3 | 0 | €1.00 | €2.78 | 178.286% |
Rhythm Pharmaceuticals | 15 | 0 | 3 | 0 | €35.60 | €45.98 | 29.157% |
XOMA Corp. | 6 | 0 | 3 | 0 | €22.00 | €68.78 | 212.633% |
Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €73.62 | €100.00 | 35.833% |
Cytokinetics Inc. | 27 | 1 | 3 | 0 | €59.50 | €85.64 | 43.938% |
Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €24.20 | €47.53 | 96.397% |
SI-BONE Inc | 17 | 1 | 2 | 0 | €14.30 | €23.59 | 64.964% |
Fate Therapeutics Inc. | 5 | 2 | 2 | 0 | €3.61 | €8.27 | 129.298% |
Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.09 | €10.00 | 23.686% |
Insmed Inc. | 13 | 1 | 2 | 0 | €24.00 | €44.01 | 83.361% |